Benzinga | Oct 28, 2020 08:33AM EDT

Raymond James Maintains Outperform on NeoGenomics, Raises Price Target to $48

Raymond James maintains NeoGenomics (NASDAQ:NEO) with a Outperform and raises the price target from $40 to $48.